Keywords: Teva, BDP allergy drug, USA, FDA, Viiv, Pfizer, GlaxoSmithKline, Epzicom

Teva gets BDP allergy drug NDA accepted by FDA; sued by ViiV over Epzicom

Article | 09 August 2011

Print This

The US Food and Drug Administration has accepted for filing Israeli generics giant Teva Pharmaceutical Industries' (Nasdaq: TEVA) New Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in